Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Endometrial Neoplasms 2Breast Neoplasms 2Smoking 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Peripheral Nervous System Diseases 1Overweight 1Obesity 1Motor Activity 1Meningioma 1Medulloblastoma 1Lymphoma, Mantle-Cell 1Lymphoma 1Localized Prostate Cancer 1Leukemia, Myeloid, Acute 1Leukemia 1Infertility 1HER2 IHC3+ Advanced Colorectal Cancer 1Genetic Diseases, Inborn 1Cognitive Dysfunction 1

Interventions

Tirzepatide 6Resistance Training 2Megestrol Acetate 2Counseling 2semaglutide 1mirabegron 1Weights and Measures 1Vitamin D 1Tablets 1Stents 1Spermine Synthase 1Specimen Handling 1Progestins 1Population Groups 1Nutrition Assessment 1Negative-Pressure Wound Therapy 1Methods 1Metformin 1Medroxyprogesterone Acetate 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Hysteroscopy 1Hydroquinones 1Estrogen Replacement Therapy 1Educational Status 1Early Intervention, Educational 1Diet Therapy 1Communication Devices for People with Disabilities 1Cholecalciferol 1Caloric Restriction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Obesity × Tablets × 90 days × Clear all
NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡